"Our study suggests that besides obesity and diabetes, GLP-1-agonists may also help in the ... Decotiis also mentioned a new ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.